index,evidence,llm_statement,indra_statement,similarity_rating,llm_explanation,llm_subject,llm_relationship,llm_object,indra_subject,indra_relationship,indra_object,subject_match,relationship_match,object_match,subject_namespace_match,object_namespace_match,match_score,match_type
1,"Recently, metformin, the most widely used first-line drug for diabetes, was found to contain a carcinogenic contaminant known as N-nitroso dimethylamine (NDMA).",a(CHEBI:metformin) isA a(CHEBI:drug),,,,a(CHEBI:metformin),isA,a(CHEBI:drug),,,,False,False,False,False,False,0.0,LLM Only
1,"Recently, metformin, the most widely used first-line drug for diabetes, was found to contain a carcinogenic contaminant known as N-nitroso dimethylamine (NDMA).","a(CHEBI:metformin) association a(CHEBI:N,N-dimethyl-4-nitrosoaniline)",,,,a(CHEBI:metformin),association,"a(CHEBI:N,N-dimethyl-4-nitrosoaniline)",,,,False,False,False,False,False,0.0,LLM Only
1,"Recently, metformin, the most widely used first-line drug for diabetes, was found to contain a carcinogenic contaminant known as N-nitroso dimethylamine (NDMA).","a(CHEBI:N,N-dimethyl-4-nitrosoaniline) isA a(CHEBI:impurity)",,,,"a(CHEBI:N,N-dimethyl-4-nitrosoaniline)",isA,a(CHEBI:impurity),,,,False,False,False,False,False,0.0,LLM Only
1,"Moreover, newer drug classes against SGLT-2 illustrate both progress and difficulties.",a(CHEBI:drug) regulates p(HGNC:SLC5A2),,,,a(CHEBI:drug),regulates,p(HGNC:SLC5A2),,,,False,False,False,False,False,0.0,LLM Only
1,The same was true previously in the case of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.,a(CHEBI:glucagon-like peptide-1 receptor agonist) isA a(CHEBI:drug),,,,a(CHEBI:glucagon-like peptide-1 receptor agonist),isA,a(CHEBI:drug),,,,False,False,False,False,False,0.0,LLM Only
1,The same was true previously in the case of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.,a(CHEBI:EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor) isA a(CHEBI:drug),,,,a(CHEBI:EC 3.4.14.5 (dipeptidyl-peptidase IV) inhibitor),isA,a(CHEBI:drug),,,,False,False,False,False,False,0.0,LLM Only
3,Phosphorylation at S326 is an important regulator of HSF1 transcriptional activity.,"p(HGNC:HSF1, pmod(Ph, Ser, 326)) increases bp(GO:""positive regulation of DNA-templated transcription initiation"")",,,,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",increases,"bp(GO:""positive regulation of DNA-templated transcription initiation"")",,,,False,False,False,False,False,0.0,LLM Only
3,"Phosphorylation at S326 is mediated by AKT1, mTOR, p38, MEK1 and DYRK2.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,"act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
3,"Phosphorylation at S326 is mediated by AKT1, mTOR, p38, MEK1 and DYRK2.","act(p(HGNC:MTOR), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,"act(p(HGNC:MTOR), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
3,"Phosphorylation at S326 is mediated by AKT1, mTOR, p38, MEK1 and DYRK2.","act(p(HGNC:MAP2K1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,"act(p(HGNC:MAP2K1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
3,"Phosphorylation at S326 is mediated by AKT1, mTOR, p38, MEK1 and DYRK2.","act(p(HGNC:DYRK2), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,"act(p(HGNC:DYRK2), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
3,"Here, we observed activation of HSF1 by AKT1 independently of mTOR.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) increases act(p(HGNC:HSF1))",,,,"act(p(HGNC:AKT1), ma(GO:""kinase activity""))",increases,act(p(HGNC:HSF1)),,,,False,False,False,False,False,0.0,LLM Only
3,AKT2 also phosphorylated S326 of HSF1 but showed weak ability to activate HSF1.,"act(p(HGNC:AKT2), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:392 ! AKT2) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Good,"Both statements describe the same biological event where AKT2 kinase activity directly increases the phosphorylation of HSF1 at Serine 326. The only difference is in the way phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT2), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT2),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,True,True,True,0.7710227272727274,Best Match
3,AKT2 also phosphorylated S326 of HSF1 but showed weak ability to activate HSF1.,"act(p(HGNC:AKT2), ma(GO:""kinase activity"")) increases act(p(HGNC:HSF1))","p(HGNC:392 ! AKT2) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements indicate that AKT2 increases the activity of HSF1. However, the INDRA statement specifies that this increase is direct and involves protein phosphorylation at Serine 326, while the LLM statement does not provide these details.","act(p(HGNC:AKT2), ma(GO:""kinase activity""))",increases,act(p(HGNC:HSF1)),p(HGNC:AKT2),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,False,False,True,True,0.2573863636363636,Best Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 142))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",Good,"Both statements describe the same biological event where AKT1 kinase activity leads to the phosphorylation of HSF1 at Threonine 142. The only difference is in the way protein phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 142))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",False,True,True,True,True,0.7710227272727274,Best Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 142))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",Medium,"Both statements describe a direct increase relationship where AKT1 influences HSF1. However, the phosphorylation site differs between the two statements (Thr142 vs Thr527), which could imply different biological outcomes.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 142))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",False,True,False,True,True,0.6645833333333334,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 142))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1. However, the modification sites and types are different: the LLM statement mentions a phosphorylation at Threonine 142, while the INDRA statement mentions a phosphorylation at Serine 326.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 142))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 142))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1. However, the modification type and site differ: the LLM statement describes a phosphorylation at Threonine 142, while the INDRA statement describes a phosphorylation at Serine 230.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 142))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 230))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",Good,"Both statements describe the same biological event where AKT1 kinase activity leads to the phosphorylation of HSF1 at Serine 230. The only difference is in the way phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 230))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",False,True,True,True,True,0.7710227272727274,Best Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 230))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements describe a similar biological event where AKT1 increases the phosphorylation of HSF1. However, the phosphorylation site differs between the two statements (Ser230 vs Ser326), which could potentially lead to different biological outcomes.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 230))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,False,True,True,0.6645833333333334,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 230))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1. However, the post-translational modifications (pmod) are different, with the LLM statement indicating phosphorylation at Serine 230 and the INDRA statement indicating phosphorylation at Threonine 527.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 230))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 230))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1. However, the post-translational modifications (pmod) are different in terms of the type of modification and the position of the modification. In the LLM statement, it's a phosphorylation at Serine 230, while in the INDRA statement, it's a phosphorylation at Threonine 142.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 230))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 527))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",Good,"Both statements describe the same biological event where AKT1 kinase activity directly increases the phosphorylation of HSF1 at Threonine 527. The only difference is in the way protein phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 527))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 527))",False,True,True,True,True,0.7710227272727274,Best Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 527))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1, but the phosphorylation sites and GO terms are different. In the LLM statement, HSF1 is phosphorylated at Thr527, while in the INDRA statement, it is phosphorylated at Thr142. Also, the GO term for kinase activity is used in the LLM statement, while the GO term for protein phosphorylation is used in the INDRA statement.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 527))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Thr, 142))",False,True,False,True,True,0.6645833333333334,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 527))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1. However, the modification type and site differ: the LLM statement describes phosphorylation at Threonine 527, while the INDRA statement describes phosphorylation at Serine 326.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 527))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Mass spectrometry showed that AKT1 also phosphorylated HSF1 at T142, S230 and T527 in addition to S326, whereas the other kinases did not.","act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Thr, 527))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",Medium,"Both statements describe a direct increase relationship between AKT1 and HSF1, but the post-translational modifications (pmod) are different in terms of the type of amino acid (Thr vs Ser) and the position (527 vs 230).","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Thr, 527))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 230))",False,True,False,True,True,0.6591346153846154,Secondary Match
3,"Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.","p(HGNC:HSF1, pmod(Ph, Thr, 142)) increases complex(p(HGNC:HSF1), p(HGNC:HSF1), p(HGNC:HSF1))",,,,"p(HGNC:HSF1, pmod(Ph, Thr, 142))",increases,"complex(p(HGNC:HSF1), p(HGNC:HSF1), p(HGNC:HSF1))",,,,False,False,False,False,False,0.0,LLM Only
3,"Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.","p(HGNC:HSF1, pmod(Ph, Ser, 230)) increases bp(GO:""positive regulation of DNA-templated transcription initiation"")",,,,"p(HGNC:HSF1, pmod(Ph, Ser, 230))",increases,"bp(GO:""positive regulation of DNA-templated transcription initiation"")",,,,False,False,False,False,False,0.0,LLM Only
3,"Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.","p(HGNC:HSF1, pmod(Ph, Ser, 230)) increases complex(p(HGNC:HSF1), p(HGNC:GTF2B))",,,,"p(HGNC:HSF1, pmod(Ph, Ser, 230))",increases,"complex(p(HGNC:HSF1), p(HGNC:GTF2B))",,,,False,False,False,False,False,0.0,LLM Only
3,"Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.","p(HGNC:HSF1, pmod(Ph, Ser, 230)) increases complex(p(HGNC:HSF1), p(HGNC:CDK9))",,,,"p(HGNC:HSF1, pmod(Ph, Ser, 230))",increases,"complex(p(HGNC:HSF1), p(HGNC:CDK9))",,,,False,False,False,False,False,0.0,LLM Only
3,"Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.","p(HGNC:HSF1, pmod(Ph, Ser, 326)) increases complex(p(HGNC:HSF1), p(HGNC:GTF2B))",,,,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",increases,"complex(p(HGNC:HSF1), p(HGNC:GTF2B))",,,,False,False,False,False,False,0.0,LLM Only
3,"Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.","p(HGNC:HSF1, pmod(Ph, Ser, 326)) increases complex(p(HGNC:HSF1), p(HGNC:CDK9))",,,,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",increases,"complex(p(HGNC:HSF1), p(HGNC:CDK9))",,,,False,False,False,False,False,0.0,LLM Only
3,"Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.","p(HGNC:HSF1, pmod(Ph, Thr, 527)) increases bp(GO:""positive regulation of DNA-templated transcription initiation"")",,,,"p(HGNC:HSF1, pmod(Ph, Thr, 527))",increases,"bp(GO:""positive regulation of DNA-templated transcription initiation"")",,,,False,False,False,False,False,0.0,LLM Only
3,"Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.","p(HGNC:HSF1, pmod(Ph, Thr, 527)) increases complex(p(HGNC:HSF1), p(HGNC:GTF2B))",,,,"p(HGNC:HSF1, pmod(Ph, Thr, 527))",increases,"complex(p(HGNC:HSF1), p(HGNC:GTF2B))",,,,False,False,False,False,False,0.0,LLM Only
3,"Subsequent investigation revealed that phosphorylation at T142 is necessary for HSF1 trimerization and that S230, S326 and T527 are required for HSF1 gene transactivation and recruitment of TFIIB and CDK9.","p(HGNC:HSF1, pmod(Ph, Thr, 527)) increases complex(p(HGNC:HSF1), p(HGNC:CDK9))",,,,"p(HGNC:HSF1, pmod(Ph, Thr, 527))",increases,"complex(p(HGNC:HSF1), p(HGNC:CDK9))",,,,False,False,False,False,False,0.0,LLM Only
4,"Consistent with our previous findings, AKT1 strongly induced HSF1 activity (Fig. 1A-C).",act(p(HGNC:AKT1)) increases act(p(HGNC:HSF1)),,,,act(p(HGNC:AKT1)),increases,act(p(HGNC:HSF1)),,,,False,False,False,False,False,0.0,LLM Only
4,"AKT2 promoted a significant increase in HSF1 activity, but the effect was modest while AKT3 had no significant effect on HSF1 activity (Fig. 1A-C).",act(p(HGNC:AKT2)) increases act(p(HGNC:HSF1)),,,,act(p(HGNC:AKT2)),increases,act(p(HGNC:HSF1)),,,,False,False,False,False,False,0.0,LLM Only
4,"AKT2 promoted a significant increase in HSF1 activity, but the effect was modest while AKT3 had no significant effect on HSF1 activity (Fig. 1A-C).",act(p(HGNC:AKT3)) causesNoChange act(p(HGNC:HSF1)),,,,act(p(HGNC:AKT3)),causesNoChange,act(p(HGNC:HSF1)),,,,False,False,False,False,False,0.0,LLM Only
4,Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).,"act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Good,"Both statements describe the same biological event where AKT1 kinase activity directly increases the phosphorylation of HSF1 at Serine 326. The only difference is in the way phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,True,True,True,0.7710227272727274,Best Match
4,Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).,"act(p(HGNC:AKT1), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:392 ! AKT2) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements describe a similar biological event where a protein kinase (AKT) directly increases the phosphorylation of HSF1 at Serine 326. However, the LLM statement refers to AKT1 while the INDRA statement refers to AKT2, which are different isoforms of the AKT protein.","act(p(HGNC:AKT1), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT2),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,True,True,True,0.7633838383838384,Secondary Match
4,Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).,"act(p(HGNC:AKT2), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:392 ! AKT2) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Good,"Both statements describe the same biological event where AKT2 kinase activity directly increases the phosphorylation of HSF1 at Serine 326. The only difference is in the way phosphorylation is represented, but it does not change the biological meaning.","act(p(HGNC:AKT2), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT2),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,True,True,True,0.7710227272727274,Best Match
4,Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).,"act(p(HGNC:AKT2), ma(GO:""kinase activity"")) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements describe a similar biological event where AKT increases the phosphorylation of HSF1 at Serine 326. However, the LLM statement refers to AKT2 while the INDRA statement refers to AKT1, which are different isoforms of the AKT protein.","act(p(HGNC:AKT2), ma(GO:""kinase activity""))",directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,True,True,True,True,0.7633838383838384,Secondary Match
4,Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).,"act(p(HGNC:AKT3), ma(GO:""kinase activity"")) causesNoChange p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:392 ! AKT2) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements involve the proteins AKT and HSF1, and the phosphorylation of HSF1 at Serine 326. However, the first statement suggests that AKT3 has no effect on the phosphorylation of HSF1, while the second suggests that AKT2 directly increases this phosphorylation. Also, the AKT isoforms are different in each statement.","act(p(HGNC:AKT3), ma(GO:""kinase activity""))",causesNoChange,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT2),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,False,True,True,True,0.3633838383838384,Best Match
4,Both AKT1 and AKT2 phosphorylated S326 of HSF1 at similar levels but AKT3 showed no capability for phosphorylating S326 (Fig. 1D).,"act(p(HGNC:AKT3), ma(GO:""kinase activity"")) causesNoChange p(HGNC:HSF1, pmod(Ph, Ser, 326))","p(HGNC:391 ! AKT1) directlyIncreases p(HGNC:5224 ! HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",Medium,"Both statements involve the protein HSF1 being phosphorylated at Serine 326. However, the first statement suggests that AKT3 kinase activity does not change this phosphorylation, while the second statement suggests that AKT1 directly increases this phosphorylation. The difference in the proteins (AKT3 vs AKT1) and their effects on HSF1 phosphorylation leads to a medium similarity rating.","act(p(HGNC:AKT3), ma(GO:""kinase activity""))",causesNoChange,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT1),directlyIncreases,"p(HGNC:HSF1, pmod(go:0006468 ! ""protein phosphorylation"", Ser, 326))",False,False,True,True,True,0.3633838383838384,Secondary Match
5,"These results seem contradictory because AKT2 phosphorylated S326, but the level of phosphorylation far exceeded the HSF1 activity induced by AKT2 (Fig. 1A-D).","act(p(HGNC:AKT2)) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:392 ! AKT2) increases p(HGNC:5224 ! HSF1),Medium,"Both statements indicate that AKT2 increases HSF1. However, the LLM statement specifies that this increase is direct and involves a phosphorylation modification at Serine 326, while the INDRA statement does not provide these details.",act(p(HGNC:AKT2)),directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",p(HGNC:AKT2),increases,p(HGNC:HSF1),False,False,False,True,True,0.35892857142857143,Best Match
5,AKT1 is also a well-known activator of mTOR and mTOR has been shown to phosphorylate HSF1 at S326 in response to proteotoxic stress.,act(p(HGNC:AKT1)) increases act(p(HGNC:MTOR)),,,,act(p(HGNC:AKT1)),increases,act(p(HGNC:MTOR)),,,,False,False,False,False,False,0.0,LLM Only
5,AKT1 is also a well-known activator of mTOR and mTOR has been shown to phosphorylate HSF1 at S326 in response to proteotoxic stress.,"act(p(HGNC:MTOR)) directlyIncreases p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,act(p(HGNC:MTOR)),directlyIncreases,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
5,Results indicated that rapamycin had no effect on HSF1 activity (Fig. 1F) or on S326 phosphorylation (Fig. 1G) driven by AKT1.,a(CHEBI:sirolimus) causesNoChange act(p(HGNC:HSF1)),,,,a(CHEBI:sirolimus),causesNoChange,act(p(HGNC:HSF1)),,,,False,False,False,False,False,0.0,LLM Only
5,Results indicated that rapamycin had no effect on HSF1 activity (Fig. 1F) or on S326 phosphorylation (Fig. 1G) driven by AKT1.,"a(CHEBI:sirolimus) causesNoChange p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,a(CHEBI:sirolimus),causesNoChange,"p(HGNC:HSF1, pmod(Ph, Ser, 326))",,,,False,False,False,False,False,0.0,LLM Only
6,"Introduction of AKT1 was observed to promote a significant increase in trimerization, although the AKT1-driven trimerization was not as much as heat stress (Fig. 2A-B).","p(HGNC:AKT1) increases complex(p(HGNC:HSF1), p(HGNC:HSF1), p(HGNC:HSF1))",,,,p(HGNC:AKT1),increases,"complex(p(HGNC:HSF1), p(HGNC:HSF1), p(HGNC:HSF1))",,,,False,False,False,False,False,0.0,LLM Only
6,AKT2 and AKT3 promoted on minimal amounts of HSF1 trimerization (Fig. 2A-B).,"p(HGNC:AKT2) increases complex(p(HGNC:HSF1), p(HGNC:HSF1), p(HGNC:HSF1))",,,,p(HGNC:AKT2),increases,"complex(p(HGNC:HSF1), p(HGNC:HSF1), p(HGNC:HSF1))",,,,False,False,False,False,False,0.0,LLM Only
6,AKT2 and AKT3 promoted on minimal amounts of HSF1 trimerization (Fig. 2A-B).,"p(HGNC:AKT3) increases complex(p(HGNC:HSF1), p(HGNC:HSF1), p(HGNC:HSF1))",,,,p(HGNC:AKT3),increases,"complex(p(HGNC:HSF1), p(HGNC:HSF1), p(HGNC:HSF1))",,,,False,False,False,False,False,0.0,LLM Only
6,"Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).","p(HGNC:AKT1) increases complex(p(HGNC:HSF1), p(HGNC:HSPA1A))",,,,p(HGNC:AKT1),increases,"complex(p(HGNC:HSF1), p(HGNC:HSPA1A))",,,,False,False,False,False,False,0.0,LLM Only
6,"Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).","p(HGNC:AKT1) increases complex(p(HGNC:HSF1), p(HGNC:HSPA8))",,,,p(HGNC:AKT1),increases,"complex(p(HGNC:HSF1), p(HGNC:HSPA8))",,,,False,False,False,False,False,0.0,LLM Only
6,"Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).","p(HGNC:AKT1) increases complex(p(HGNC:HSF1), p(HGNC:HSPD1))",,,,p(HGNC:AKT1),increases,"complex(p(HGNC:HSF1), p(HGNC:HSPD1))",,,,False,False,False,False,False,0.0,LLM Only
6,"Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).","p(HGNC:AKT2) causesNoChange complex(p(HGNC:HSF1), p(HGNC:HSPA1A))",,,,p(HGNC:AKT2),causesNoChange,"complex(p(HGNC:HSF1), p(HGNC:HSPA1A))",,,,False,False,False,False,False,0.0,LLM Only
6,"Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).","p(HGNC:AKT2) causesNoChange complex(p(HGNC:HSF1), p(HGNC:HSPA8))",,,,p(HGNC:AKT2),causesNoChange,"complex(p(HGNC:HSF1), p(HGNC:HSPA8))",,,,False,False,False,False,False,0.0,LLM Only
6,"Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).","p(HGNC:AKT2) causesNoChange complex(p(HGNC:HSF1), p(HGNC:HSPD1))",,,,p(HGNC:AKT2),causesNoChange,"complex(p(HGNC:HSF1), p(HGNC:HSPD1))",,,,False,False,False,False,False,0.0,LLM Only
6,"Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).","p(HGNC:AKT3) causesNoChange complex(p(HGNC:HSF1), p(HGNC:HSPA1A))",,,,p(HGNC:AKT3),causesNoChange,"complex(p(HGNC:HSF1), p(HGNC:HSPA1A))",,,,False,False,False,False,False,0.0,LLM Only
6,"Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).","p(HGNC:AKT3) causesNoChange complex(p(HGNC:HSF1), p(HGNC:HSPA8))",,,,p(HGNC:AKT3),causesNoChange,"complex(p(HGNC:HSF1), p(HGNC:HSPA8))",,,,False,False,False,False,False,0.0,LLM Only
6,"Similarly, introduction of AKT1 promoted a significant increase of HSF1 binding to putative targets HSPA1A (HSP70), HSPA8 (HSP73) and HSPD1 (HSP60), whereas AKT2 and AKT3 had no significant effect on HSF1 binding (Fig. 2C).","p(HGNC:AKT3) causesNoChange complex(p(HGNC:HSF1), p(HGNC:HSPD1))",,,,p(HGNC:AKT3),causesNoChange,"complex(p(HGNC:HSF1), p(HGNC:HSPD1))",,,,False,False,False,False,False,0.0,LLM Only
6,Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).,p(HGNC:AKT1) increases p(HGNC:HSPA1A),,,,p(HGNC:AKT1),increases,p(HGNC:HSPA1A),,,,False,False,False,False,False,0.0,LLM Only
6,These results indicate that AKT1 is the primary AKT isoform capable of activating HSF1 with AKT2 having modest effects in cells.,p(HGNC:AKT1) increases act(p(HGNC:HSF1)),,,,p(HGNC:AKT1),increases,act(p(HGNC:HSF1)),,,,False,False,False,False,False,0.0,LLM Only
7,We hypothesized that tripterine inhibits endogenous peroxynitrite formation and thereby prevents endothelial barrier dysfunction,a(CHEBI:celastrol) decreases a(CHEBI:peroxynitrite),,,,a(CHEBI:celastrol),decreases,a(CHEBI:peroxynitrite),,,,False,False,False,False,False,0.0,LLM Only
9,"The second phase, excision of a short DNA strand segment containing the lesion, is carried out by an assembly of the XPG and XPF:excision repair cross-complementing 1 (ERCC1) endonucleases, together with XPA, RPA, TFIIH, and PCNA (which can bind XPG).","complex(p(HGNC:ERCC5), p(HGNC:ERCC4), p(HGNC:ERCC1), p(HGNC:XPA), p(FPLX:RPA), p(HGNC:GTF2H3), p(HGNC:PCNA))",,,,"complex(p(HGNC:ERCC5), p(HGNC:ERCC4), p(HGNC:ERCC1), p(HGNC:XPA), p(FPLX:RPA), p(HGNC:GTF2H3), p(HGNC:PCNA))",,,,,,False,False,False,False,False,0.0,LLM Only
9,"The second phase, excision of a short DNA strand segment containing the lesion, is carried out by an assembly of the XPG and XPF:excision repair cross-complementing 1 (ERCC1) endonucleases, together with XPA, RPA, TFIIH, and PCNA (which can bind XPG).","complex(p(HGNC:PCNA), p(HGNC:ERCC5))",,,,"complex(p(HGNC:PCNA), p(HGNC:ERCC5))",,,,,,False,False,False,False,False,0.0,LLM Only
9,"This assembly appears to be held together in part through RPA, which binds to single-stranded DNA (ssDNA) regions in the vicinity of lesion, and at the same time may be able to bind XPG and XPF:ERCC1, as well as XPA.","complex(p(FPLX:RPA), a(CHEBI:single-stranded DNA))",,,,"complex(p(FPLX:RPA), a(CHEBI:single-stranded DNA))",,,,,,False,False,False,False,False,0.0,LLM Only
9,"This assembly appears to be held together in part through RPA, which binds to single-stranded DNA (ssDNA) regions in the vicinity of lesion, and at the same time may be able to bind XPG and XPF:ERCC1, as well as XPA.","complex(p(FPLX:RPA), p(HGNC:ERCC5))",,,,"complex(p(FPLX:RPA), p(HGNC:ERCC5))",,,,,,False,False,False,False,False,0.0,LLM Only
9,"This assembly appears to be held together in part through RPA, which binds to single-stranded DNA (ssDNA) regions in the vicinity of lesion, and at the same time may be able to bind XPG and XPF:ERCC1, as well as XPA.","complex(p(FPLX:RPA), p(HGNC:ERCC4), p(HGNC:ERCC1))",,,,"complex(p(FPLX:RPA), p(HGNC:ERCC4), p(HGNC:ERCC1))",,,,,,False,False,False,False,False,0.0,LLM Only
9,"This assembly appears to be held together in part through RPA, which binds to single-stranded DNA (ssDNA) regions in the vicinity of lesion, and at the same time may be able to bind XPG and XPF:ERCC1, as well as XPA.","complex(p(FPLX:RPA), p(HGNC:XPA))",,,,"complex(p(FPLX:RPA), p(HGNC:XPA))",,,,,,False,False,False,False,False,0.0,LLM Only
9,"In going from the recognition to the excision phase, the molecular assembly rearranges as XPC:HR23B is replaced by XPG.","p(HGNC:ERCC5) directlyDecreases complex(p(HGNC:XPC), p(HGNC:RAD23B))",,,,p(HGNC:ERCC5),directlyDecreases,"complex(p(HGNC:XPC), p(HGNC:RAD23B))",,,,False,False,False,False,False,0.0,LLM Only
11,"Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.","act(p(HGNC:DYRK1A)) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 522))","p(HGNC:14929 ! SIRT1) directlyDecreases p(HGNC:11998 ! TP53, pmod(go:0006473 ! ""protein acetylation""))",Bad,"The two statements are quite different in their biological meaning. The first statement indicates that DYRK1A increases the phosphorylation of SIRT1 at Thr522, while the second statement suggests that SIRT1 decreases the acetylation of TP53. The subjects, objects, and relationships are all different.",act(p(HGNC:DYRK1A)),directlyIncreases,"p(HGNC:SIRT1, pmod(Ph, Thr, 522))",p(HGNC:SIRT1),directlyDecreases,"p(HGNC:TP53, pmod(go:0006473 ! ""protein acetylation""))",False,False,False,True,True,0.3325,Best Match
11,"Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.","act(p(HGNC:DYRK3)) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 522))","p(HGNC:14929 ! SIRT1) directlyDecreases p(HGNC:11998 ! TP53, pmod(go:0006473 ! ""protein acetylation""))",Bad,"The two statements are quite different in their biological meaning. The first statement indicates that DYRK3 increases the phosphorylation of SIRT1 at Thr522, while the second statement suggests that SIRT1 decreases the acetylation of TP53. The subjects, objects, and relationships are all different.",act(p(HGNC:DYRK3)),directlyIncreases,"p(HGNC:SIRT1, pmod(Ph, Thr, 522))",p(HGNC:SIRT1),directlyDecreases,"p(HGNC:TP53, pmod(go:0006473 ! ""protein acetylation""))",False,False,False,True,True,0.3325,Best Match
11,"Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.","p(HGNC:SIRT1, pmod(Ph, Thr, 522)) increases act(p(HGNC:SIRT1))","p(HGNC:14929 ! SIRT1) directlyDecreases p(HGNC:11998 ! TP53, pmod(go:0006473 ! ""protein acetylation""))",Bad,"The two statements are not similar. The first statement is about the phosphorylation of SIRT1 increasing its activity, while the second statement is about SIRT1 decreasing the acetylation of TP53.","p(HGNC:SIRT1, pmod(Ph, Thr, 522))",increases,act(p(HGNC:SIRT1)),p(HGNC:SIRT1),directlyDecreases,"p(HGNC:TP53, pmod(go:0006473 ! ""protein acetylation""))",False,False,False,True,True,0.3314285714285714,Best Match
11,"Kinases DYRK1A and DYRK3 have been shown to phosphorylate human SIRT1 at T522, stimulating the deacetylation of p53 by SIRT1; phosphorylation at this site increases the rate of product release by SIRT1.","act(p(HGNC:SIRT1)) directlyDecreases p(HGNC:TP53, pmod(Ac, Lys))","p(HGNC:14929 ! SIRT1) directlyDecreases p(HGNC:11998 ! TP53, pmod(go:0006473 ! ""protein acetylation""))",Good,"Both statements describe the same biological event where the protein SIRT1 directly decreases the acetylation of the protein TP53. The difference in the statements is only in the way acetylation is represented, but it does not change the biological meaning.",act(p(HGNC:SIRT1)),directlyDecreases,"p(HGNC:TP53, pmod(Ac, Lys))",p(HGNC:SIRT1),directlyDecreases,"p(HGNC:TP53, pmod(go:0006473 ! ""protein acetylation""))",False,True,False,True,True,0.7575000000000001,Best Match
11,"AMPK phosphorylates human SIRT1 at T344 inhibiting its ability to decacetylate p53, a known target of SIRT1.","act(p(FPLX:AMPK)) directlyIncreases p(HGNC:SIRT1, pmod(Ph, Thr, 344))",,,,act(p(FPLX:AMPK)),directlyIncreases,"p(HGNC:SIRT1, pmod(Ph, Thr, 344))",,,,False,False,False,False,False,0.0,LLM Only
11,"AMPK phosphorylates human SIRT1 at T344 inhibiting its ability to decacetylate p53, a known target of SIRT1.","p(HGNC:SIRT1, pmod(Ph, Thr, 344)) decreases act(p(HGNC:SIRT1))",,,,"p(HGNC:SIRT1, pmod(Ph, Thr, 344))",decreases,act(p(HGNC:SIRT1)),,,,False,False,False,False,False,0.0,LLM Only
11,"In addition to phosphorylation, methylation of SIRT1 by Set7/9 at K233, K235, K236, and K238 inhibits the SIRT1-mediated deacetylation of p53 in response to DNA damage.","p(HGNC:SETD7) directlyIncreases p(HGNC:SIRT1, pmod(Me, Lys, 233), pmod(Me, Lys, 235), pmod(Me, Lys, 236), pmod(Me, Lys, 238))",,,,p(HGNC:SETD7),directlyIncreases,"p(HGNC:SIRT1, pmod(Me, Lys, 233), pmod(Me, Lys, 235), pmod(Me, Lys, 236), pmod(Me, Lys, 238))",,,,False,False,False,False,False,0.0,LLM Only
11,"In addition to phosphorylation, methylation of SIRT1 by Set7/9 at K233, K235, K236, and K238 inhibits the SIRT1-mediated deacetylation of p53 in response to DNA damage.","p(HGNC:SIRT1, pmod(Me, Lys, 233), pmod(Me, Lys, 235), pmod(Me, Lys, 236), pmod(Me, Lys, 238)) decreases act(p(HGNC:SIRT1))",,,,"p(HGNC:SIRT1, pmod(Me, Lys, 233), pmod(Me, Lys, 235), pmod(Me, Lys, 236), pmod(Me, Lys, 238))",decreases,act(p(HGNC:SIRT1)),,,,False,False,False,False,False,0.0,LLM Only
11,"Sumoylation at K734 by SUMO1 increases, whereas desumoylation by SENP1 decreases, the activity of SIRT1 in response to genotoxic stress.","p(HGNC:SUMO1) directlyIncreases p(HGNC:SIRT1, pmod(Sumo, Lys, 734))",,,,p(HGNC:SUMO1),directlyIncreases,"p(HGNC:SIRT1, pmod(Sumo, Lys, 734))",,,,False,False,False,False,False,0.0,LLM Only
11,"Sumoylation at K734 by SUMO1 increases, whereas desumoylation by SENP1 decreases, the activity of SIRT1 in response to genotoxic stress.","p(HGNC:SIRT1, pmod(Sumo, Lys, 734)) increases act(p(HGNC:SIRT1))",,,,"p(HGNC:SIRT1, pmod(Sumo, Lys, 734))",increases,act(p(HGNC:SIRT1)),,,,False,False,False,False,False,0.0,LLM Only
11,"Sumoylation at K734 by SUMO1 increases, whereas desumoylation by SENP1 decreases, the activity of SIRT1 in response to genotoxic stress.",act(p(HGNC:SENP1)) directlyDecreases act(p(HGNC:SIRT1)),,,,act(p(HGNC:SENP1)),directlyDecreases,act(p(HGNC:SIRT1)),,,,False,False,False,False,False,0.0,LLM Only
11,"In this study, genotoxic stress promoted the association of SIRT1 with SENP1, which may help to inhibit the ability of SIRT1 to promote survival.",p(HGNC:SIRT1) association p(HGNC:SENP1),,,,p(HGNC:SIRT1),association,p(HGNC:SENP1),,,,False,False,False,False,False,0.0,LLM Only
11,"Additionally, transnitrosylation of SIRT1 by GAPDH at C387 and C390 has been found to inhibit the activity of SIRT1 leading to decreased PGC1b1 transcriptional activity; PGC1b1 is an important regulator of metabolism and mitochondrial function.","p(HGNC:GAPDH) directlyIncreases p(HGNC:SIRT1, pmod(NO, Cys, 387), pmod(NO, Cys, 390))",,,,p(HGNC:GAPDH),directlyIncreases,"p(HGNC:SIRT1, pmod(NO, Cys, 387), pmod(NO, Cys, 390))",,,,False,False,False,False,False,0.0,LLM Only
11,"Additionally, transnitrosylation of SIRT1 by GAPDH at C387 and C390 has been found to inhibit the activity of SIRT1 leading to decreased PGC1b1 transcriptional activity; PGC1b1 is an important regulator of metabolism and mitochondrial function.","p(HGNC:SIRT1, pmod(NO, Cys, 387), pmod(NO, Cys, 390)) decreases act(p(HGNC:SIRT1))",,,,"p(HGNC:SIRT1, pmod(NO, Cys, 387), pmod(NO, Cys, 390))",decreases,act(p(HGNC:SIRT1)),,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.","p(HGNC:SIRT1) association p(HGNC:SIRT1, loc(GO:nucleus))",,,,p(HGNC:SIRT1),association,"p(HGNC:SIRT1, loc(GO:nucleus))",,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.","p(HGNC:SIRT6) association p(HGNC:SIRT6, loc(GO:nucleus))",,,,p(HGNC:SIRT6),association,"p(HGNC:SIRT6, loc(GO:nucleus))",,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.","p(HGNC:SIRT7) association p(HGNC:SIRT7, loc(GO:nucleus))",,,,p(HGNC:SIRT7),association,"p(HGNC:SIRT7, loc(GO:nucleus))",,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.","p(HGNC:SIRT2) association p(HGNC:SIRT2, loc(GO:cytoplasm))",,,,p(HGNC:SIRT2),association,"p(HGNC:SIRT2, loc(GO:cytoplasm))",,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.","p(HGNC:SIRT3) association p(HGNC:SIRT3, loc(GO:mitochondrion))",,,,p(HGNC:SIRT3),association,"p(HGNC:SIRT3, loc(GO:mitochondrion))",,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.","p(HGNC:SIRT4) association p(HGNC:SIRT4, loc(GO:mitochondrion))",,,,p(HGNC:SIRT4),association,"p(HGNC:SIRT4, loc(GO:mitochondrion))",,,,False,False,False,False,False,0.0,LLM Only
12,"Three of the sirtuins, SIRT1, SIRT6, and SIRT7 localize to the nucleus, SIRT2 is mainly localized in the cytoplasm, while the remaining three sirtuins: SIRT3, SIRT4, and SIRT5 are found in the mitochondria.","p(HGNC:SIRT5) association p(HGNC:SIRT5, loc(GO:mitochondrion))",,,,p(HGNC:SIRT5),association,"p(HGNC:SIRT5, loc(GO:mitochondrion))",,,,False,False,False,False,False,0.0,LLM Only
12,This review will focus on SIRT1 (EC 3.5.1.-) a member of the sirtuin family that is expressed in many tissues and acts as a NAD+-dependent protein deacetylase.,"a(CHEBI:""NAD(+)"") increases act(p(HGNC:SIRT1))",,,,"a(CHEBI:""NAD(+)"")",increases,act(p(HGNC:SIRT1)),,,,False,False,False,False,False,0.0,LLM Only
12,"SIRT1 has been implicated in signaling pathways underlying various diseases, including: diabetes, cardiovascular disease, neurodegeneration, cancer, aging, and obesity.","p(HGNC:SIRT1) increases bp(GO:""signal transduction"")",,,,p(HGNC:SIRT1),increases,"bp(GO:""signal transduction"")",,,,False,False,False,False,False,0.0,LLM Only
13,"NF-kappaB signaling exerts anti-apoptotic and cyto-protective properties, which is illustrated by many genetic in vivo models, in which deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).","act(a(FPLX:NFkappaB)) decreases bp(GO:""apoptotic process"")",,,,act(a(FPLX:NFkappaB)),decreases,"bp(GO:""apoptotic process"")",,,,False,False,False,False,False,0.0,LLM Only
13,"NF-kappaB signaling exerts anti-apoptotic and cyto-protective properties, which is illustrated by many genetic in vivo models, in which deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).","act(a(FPLX:NFkappaB)) decreases bp(GO:""cell death"")",,,,act(a(FPLX:NFkappaB)),decreases,"bp(GO:""cell death"")",,,,False,False,False,False,False,0.0,LLM Only
13,"NF-kappaB signaling exerts anti-apoptotic and cyto-protective properties, which is illustrated by many genetic in vivo models, in which deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).","p(HGNC:MAP3K7) decreases bp(GO:""cell death"")",,,,p(HGNC:MAP3K7),decreases,"bp(GO:""cell death"")",,,,False,False,False,False,False,0.0,LLM Only
13,"NF-kappaB signaling exerts anti-apoptotic and cyto-protective properties, which is illustrated by many genetic in vivo models, in which deficiency of central pathway constituents, such as TAK1, IKKss, and IKKgamma induced massive hepatocellular cell death (Luedde and Schwabe,).","p(HGNC:IKBKG) decreases bp(GO:""cell death"")",,,,p(HGNC:IKBKG),decreases,"bp(GO:""cell death"")",,,,False,False,False,False,False,0.0,LLM Only
13,"This apoptosis in the absence of NF-kappaB depends on the persistent activation of the JNK axis followed by the production of reactive oxygen species (ROS) (Chen et al.,).","act(a(FPLX:JNK)) increases a(CHEBI:""reactive oxygen species"")",,,,act(a(FPLX:JNK)),increases,"a(CHEBI:""reactive oxygen species"")",,,,False,False,False,False,False,0.0,LLM Only
13,"This apoptosis in the absence of NF-kappaB depends on the persistent activation of the JNK axis followed by the production of reactive oxygen species (ROS) (Chen et al.,).","a(CHEBI:""reactive oxygen species"") increases bp(GO:""apoptotic process"")",,,,"a(CHEBI:""reactive oxygen species"")",increases,"bp(GO:""apoptotic process"")",,,,False,False,False,False,False,0.0,LLM Only
13,"Interestingly, previous experiments demonstrated that TNF activated NF-kappaB and JNK signaling with different dynamics (Iqbal and Zaidi,), suggesting the existence of intra-cellular decision making processes discriminating between cyto-protection via NF-kappaB and programmed cell death via JNK.",p(HGNC:TNF) increases a(FPLX:NFkappaB),,,,p(HGNC:TNF),increases,a(FPLX:NFkappaB),,,,False,False,False,False,False,0.0,LLM Only
13,"Interestingly, previous experiments demonstrated that TNF activated NF-kappaB and JNK signaling with different dynamics (Iqbal and Zaidi,), suggesting the existence of intra-cellular decision making processes discriminating between cyto-protection via NF-kappaB and programmed cell death via JNK.",p(HGNC:TNF) increases a(FPLX:JNK),,,,p(HGNC:TNF),increases,a(FPLX:JNK),,,,False,False,False,False,False,0.0,LLM Only
14,"Biological functions of TNF and subsequent activation of the NF-kappaB signaling pathway are associated with inflammatory processes, hepatocyte proliferation in response to acute or chronic liver damage, as well as tumorigenesis (DiDonato et al.,).","p(HGNC:TNF) association bp(GO:""hepatocyte proliferation"")","p(HGNC:11892 ! TNF) increases bp(GO:""GO:0007165"" ! ""signal transduction"")",Bad,"The two statements are quite different. The first statement suggests an association between TNF and hepatocyte proliferation, while the second statement suggests that TNF increases signal transduction. The subjects are the same (TNF), but the objects and relationships are different.",p(HGNC:TNF),association,"bp(GO:""hepatocyte proliferation"")",p(HGNC:TNF),increases,"bp(GO:""GO:0007165"" ! ""signal transduction"")",True,False,False,True,True,0.4642857142857143,Best Match
14,"Biological functions of TNF and subsequent activation of the NF-kappaB signaling pathway are associated with inflammatory processes, hepatocyte proliferation in response to acute or chronic liver damage, as well as tumorigenesis (DiDonato et al.,).","p(HGNC:TNF) association bp(GO:""hepatocyte proliferation"")",p(HGNC:11892 ! TNF) increases p(FPLX:NFkappaB ! NFkappaB),Bad,"The two statements are quite different in their biological meaning. The first statement suggests an association between TNF and hepatocyte proliferation, while the second statement indicates that TNF increases NFkappaB. There is no overlap in the objects (hepatocyte proliferation vs NFkappaB) or the relationships (association vs increase) between the two statements.",p(HGNC:TNF),association,"bp(GO:""hepatocyte proliferation"")",p(HGNC:TNF),increases,p(FPLX:NFkappaB),True,False,False,True,False,0.3,Secondary Match
15,"For example, A20 suppresses apoptotic JNK signaling in a TNF-dependent and independent manner via induction of ASK1 degradation (Won et al.,).",p(HGNC:TNFAIP3) decreases act(p(FPLX:JNK)),,,,p(HGNC:TNFAIP3),decreases,act(p(FPLX:JNK)),,,,False,False,False,False,False,0.0,LLM Only
15,"For example, A20 suppresses apoptotic JNK signaling in a TNF-dependent and independent manner via induction of ASK1 degradation (Won et al.,).",p(HGNC:TNFAIP3) decreases p(HGNC:MAP3K5),,,,p(HGNC:TNFAIP3),decreases,p(HGNC:MAP3K5),,,,False,False,False,False,False,0.0,LLM Only
15,"For example, A20 suppresses apoptotic JNK signaling in a TNF-dependent and independent manner via induction of ASK1 degradation (Won et al.,).","p(HGNC:TNFAIP3) decreases bp(GO:""apoptotic process"")",,,,p(HGNC:TNFAIP3),decreases,"bp(GO:""apoptotic process"")",,,,False,False,False,False,False,0.0,LLM Only
15,Since A20 is efficiently induced by TNF administration it is tempting to speculate that the loss of ASK1 might shift the cellular response from apoptosis to survival and proliferation.,p(HGNC:TNF) increases p(HGNC:TNFAIP3),,,,p(HGNC:TNF),increases,p(HGNC:TNFAIP3),,,,False,False,False,False,False,0.0,LLM Only
15,"ASK1 can phosphorylate JNK and the physical interaction between A20 and ASK1 has been demonstrated (Tobiume et al.,; Won et al.,).","act(p(HGNC:MAP3K5)) directlyIncreases p(FPLX:JNK, pmod(Ph))",,,,act(p(HGNC:MAP3K5)),directlyIncreases,"p(FPLX:JNK, pmod(Ph))",,,,False,False,False,False,False,0.0,LLM Only
15,"ASK1 can phosphorylate JNK and the physical interaction between A20 and ASK1 has been demonstrated (Tobiume et al.,; Won et al.,).","complex(p(HGNC:TNFAIP3), p(HGNC:MAP3K5))",,,,"complex(p(HGNC:TNFAIP3), p(HGNC:MAP3K5))",,,,,,False,False,False,False,False,0.0,LLM Only
15,"We here showed that TNF affects the interaction between A20 and ASK1, which could explain the ASK1-dependent phosphorylation of JNK at specific periods after TNF administration.","p(HGNC:TNF) regulates complex(p(HGNC:TNFAIP3), p(HGNC:MAP3K5))",,,,p(HGNC:TNF),regulates,"complex(p(HGNC:TNFAIP3), p(HGNC:MAP3K5))",,,,False,False,False,False,False,0.0,LLM Only
16,"Once the C1 complex is bound to the cell surface, the proteases are activated and are able to cleave another complement protein, C4 into the anaphylatoxin C4a and C4b.",act(p(FPLX:C1)) directlyIncreases p(HGNC:C4A),,,,act(p(FPLX:C1)),directlyIncreases,p(HGNC:C4A),,,,False,False,False,False,False,0.0,LLM Only
16,"Once the C1 complex is bound to the cell surface, the proteases are activated and are able to cleave another complement protein, C4 into the anaphylatoxin C4a and C4b.",act(p(FPLX:C1)) directlyIncreases p(HGNC:C4B),,,,act(p(FPLX:C1)),directlyIncreases,p(HGNC:C4B),,,,False,False,False,False,False,0.0,LLM Only
16,"This cleavage causes a large conformational change in C4b, allowing it to covalently bind to cell surfaces and bind another complement protein, C2.","p(HGNC:C4B) directlyIncreases complex(p(HGNC:C4B), p(HGNC:C2))",,,,p(HGNC:C4B),directlyIncreases,"complex(p(HGNC:C4B), p(HGNC:C2))",,,,False,False,False,False,False,0.0,LLM Only
16,"C2 is then cleaved into the activation peptide, C2b, and the protease containing C2a.","complex(p(HGNC:C4B), p(HGNC:C2)) directlyIncreases act(p(HGNC:C2))",,,,"complex(p(HGNC:C4B), p(HGNC:C2))",directlyIncreases,act(p(HGNC:C2)),,,,False,False,False,False,False,0.0,LLM Only
16,"The complex of C4b and C2a (C4b2a) is a serine protease that specifically cleaves C3 into the anaphylatoxin C3a and the active form of C3, C3b, which is then able to covalently bind to the cell surfaces.","act(complex(p(HGNC:C4B), p(HGNC:C2))) directlyIncreases p(HGNC:C3)",,,,"act(complex(p(HGNC:C4B), p(HGNC:C2)))",directlyIncreases,p(HGNC:C3),,,,False,False,False,False,False,0.0,LLM Only
17,"For example, in the fluid phase, factor H can bind to C3b, preventing the formation of the C3 convertase.","complex(p(HGNC:CFH), p(HGNC:C3))",,,,"complex(p(HGNC:CFH), p(HGNC:C3))",,,,,,False,False,False,False,False,0.0,LLM Only
17,"Once bound to see C3b, factor H serves as a co-factor, allowing another compliment protein, factor I, to cleave C3b, thus inactivating it.",p(HGNC:CFH) decreases p(HGNC:C3),,,,p(HGNC:CFH),decreases,p(HGNC:C3),,,,False,False,False,False,False,0.0,LLM Only
18,"Injection of IgG, which also activates complement, into the paws of rats caused neuropathic pain symptoms.","act(complex(GO:""IgG immunoglobulin complex"")) increases bp(GO:""complement activation"")",,,,"act(complex(GO:""IgG immunoglobulin complex""))",increases,"bp(GO:""complement activation"")",,,,False,False,False,False,False,0.0,LLM Only
19,Signaling lymphocytic activation molecule family 1 (SLAMF1) is an Ig-like receptor and a costimulatory molecule that initiates signal transduction networks in a variety of immune cells.,"p(HGNC:SLAMF1) increases bp(GO:""signal transduction"")",,,,p(HGNC:SLAMF1),increases,"bp(GO:""signal transduction"")",,,,False,False,False,False,False,0.0,LLM Only
19,"In this study, we report that SLAMF1 is required for Toll-like receptor 4 (TLR4)-mediated induction of interferon beta (IFNbeta) and for killing of Gram-negative bacteria by human macrophages.",p(HGNC:SLAMF1) increases act(p(HGNC:TLR4)),p(HGNC:11850 ! TLR4) increases p(HGNC:11850 ! TLR4),Bad,"The two statements are not similar. The LLM statement suggests that SLAMF1 protein increases the activity of TLR4 protein, while the INDRA statement suggests that TLR4 protein increases itself, which is biologically less meaningful.",p(HGNC:SLAMF1),increases,act(p(HGNC:TLR4)),p(HGNC:TLR4),increases,p(HGNC:TLR4),False,True,False,True,True,0.7625000000000001,Best Match
19,"In this study, we report that SLAMF1 is required for Toll-like receptor 4 (TLR4)-mediated induction of interferon beta (IFNbeta) and for killing of Gram-negative bacteria by human macrophages.",p(HGNC:SLAMF1) increases act(p(HGNC:TLR4)),p(HGNC:11850 ! TLR4) increases p(HGNC:5434 ! IFNB1),Bad,"The two statements are quite different. The first statement suggests that SLAMF1 protein increases the activity of TLR4 protein, while the second statement suggests that TLR4 protein increases the production of IFNB1 protein. The subjects, objects, and relationships are all different.",p(HGNC:SLAMF1),increases,act(p(HGNC:TLR4)),p(HGNC:TLR4),increases,p(HGNC:IFNB1),False,True,False,True,True,0.7450000000000001,Secondary Match
19,"In this study, we report that SLAMF1 is required for Toll-like receptor 4 (TLR4)-mediated induction of interferon beta (IFNbeta) and for killing of Gram-negative bacteria by human macrophages.",p(HGNC:SLAMF1) increases act(p(HGNC:TLR4)),p(HGNC:11850 ! TLR4) increases p(FPLX:IFNB ! IFNB),Bad,"The two statements are quite different both in terms of the subject and the object. In the first statement, SLAMF1 is increasing the activity of TLR4, while in the second statement, TLR4 is increasing the production of IFNB. The biological processes involved are different.",p(HGNC:SLAMF1),increases,act(p(HGNC:TLR4)),p(HGNC:TLR4),increases,p(FPLX:IFNB),False,True,False,True,False,0.5833333333333334,Secondary Match
19,We found that SLAMF1 controls trafficking of the Toll receptor-associated molecule (TRAM) from the endocytic recycling compartment (ERC) to Escherichia coli phagosomes.,"p(HGNC:SLAMF1) increases p(HGNC:TICAM2, loc(GO:""phagocytic vesicle""))","p(HGNC:10903 ! SLAMF1) partOf complex(p(HGNC:10903 ! SLAMF1), p(HGNC:20568 ! TRAM1))",Bad,"The two statements are quite different in their biological meaning. The LLM statement suggests that SLAMF1 protein increases the location of TICAM2 protein in the phagocytic vesicle, while the INDRA statement indicates that SLAMF1 protein is part of a complex with TRAM1 protein. The subjects are the same but the objects and relationships are different.",p(HGNC:SLAMF1),increases,"p(HGNC:TICAM2, loc(GO:""phagocytic vesicle""))",p(HGNC:SLAMF1),partOf,"complex(p(HGNC:SLAMF1), p(HGNC:TRAM1))",True,False,False,True,True,0.385,Best Match
19,We found that SLAMF1 controls trafficking of the Toll receptor-associated molecule (TRAM) from the endocytic recycling compartment (ERC) to Escherichia coli phagosomes.,"p(HGNC:SLAMF1) decreases p(HGNC:TICAM2, loc(GO:""recycling endosome""))","p(HGNC:10903 ! SLAMF1) partOf complex(p(HGNC:10903 ! SLAMF1), p(HGNC:20568 ! TRAM1))",Bad,"The two statements are quite different. The first statement indicates that SLAMF1 decreases the activity of TICAM2 in the recycling endosome, while the second statement suggests that SLAMF1 is part of a complex with TRAM1. There is no overlap in the biological processes or interactions described.",p(HGNC:SLAMF1),decreases,"p(HGNC:TICAM2, loc(GO:""recycling endosome""))",p(HGNC:SLAMF1),partOf,"complex(p(HGNC:SLAMF1), p(HGNC:TRAM1))",True,False,False,True,True,0.385,Best Match
19,"In resting macrophages, SLAMF1 is localized to ERC, but upon addition of E. coli, it is trafficked together with TRAM from ERC to E. coli phagosomes in a Rab11-dependent manner.",p(HGNC:SLAMF1) association p(HGNC:TICAM2),,,,p(HGNC:SLAMF1),association,p(HGNC:TICAM2),,,,False,False,False,False,False,0.0,LLM Only
19,We found that endogenous SLAMF1 protein interacted with TRAM and defined key interaction domains as amino acids 68 to 95 of TRAM as well as 15 C-terminal amino acids of SLAMF1.,"complex(p(HGNC:SLAMF1), p(HGNC:TICAM2))",,,,"complex(p(HGNC:SLAMF1), p(HGNC:TICAM2))",,,,,,False,False,False,False,False,0.0,LLM Only
20,"TLR4 recognizes lipopolysaccharide (LPS) from Gram-negative bacteria in complex with the coreceptors myeloid differentiation factor 2 and CD14, and it recruits signaling adapters myeloid differentiation primary response gene 88 (MyD88) and MyD88 adapter-like (Mal).",p(HGNC:TLR4) association a(CHEBI:lipopolysaccharide),,,,p(HGNC:TLR4),association,a(CHEBI:lipopolysaccharide),,,,False,False,False,False,False,0.0,LLM Only
20,"TLR4 recognizes lipopolysaccharide (LPS) from Gram-negative bacteria in complex with the coreceptors myeloid differentiation factor 2 and CD14, and it recruits signaling adapters myeloid differentiation primary response gene 88 (MyD88) and MyD88 adapter-like (Mal).",p(HGNC:TLR4) association p(HGNC:CD14),,,,p(HGNC:TLR4),association,p(HGNC:CD14),,,,False,False,False,False,False,0.0,LLM Only
20,"TLR4 recognizes lipopolysaccharide (LPS) from Gram-negative bacteria in complex with the coreceptors myeloid differentiation factor 2 and CD14, and it recruits signaling adapters myeloid differentiation primary response gene 88 (MyD88) and MyD88 adapter-like (Mal).","p(HGNC:TLR4) directlyIncreases complex(p(HGNC:TLR4), p(HGNC:MYD88))",,,,p(HGNC:TLR4),directlyIncreases,"complex(p(HGNC:TLR4), p(HGNC:MYD88))",,,,False,False,False,False,False,0.0,LLM Only
20,"TLR4 recognizes lipopolysaccharide (LPS) from Gram-negative bacteria in complex with the coreceptors myeloid differentiation factor 2 and CD14, and it recruits signaling adapters myeloid differentiation primary response gene 88 (MyD88) and MyD88 adapter-like (Mal).","p(HGNC:TLR4) directlyIncreases complex(p(HGNC:TLR4), p(HGNC:MAL))",,,,p(HGNC:TLR4),directlyIncreases,"complex(p(HGNC:TLR4), p(HGNC:MAL))",,,,False,False,False,False,False,0.0,LLM Only
20,TLR4 is also present on endosomes and phagosomes to which the signaling adapter Toll receptor-associated molecule (TRAM) is recruited.,"p(HGNC:TLR4, loc(GO:endosome)) directlyIncreases p(HGNC:TICAM2, loc(GO:endosome))",,,,"p(HGNC:TLR4, loc(GO:endosome))",directlyIncreases,"p(HGNC:TICAM2, loc(GO:endosome))",,,,False,False,False,False,False,0.0,LLM Only
20,TLR4 is also present on endosomes and phagosomes to which the signaling adapter Toll receptor-associated molecule (TRAM) is recruited.,"p(HGNC:TLR4, loc(GO:""phagocytic vesicle"")) directlyIncreases p(HGNC:TICAM2, loc(GO:""phagocytic vesicle""))",,,,"p(HGNC:TLR4, loc(GO:""phagocytic vesicle""))",directlyIncreases,"p(HGNC:TICAM2, loc(GO:""phagocytic vesicle""))",,,,False,False,False,False,False,0.0,LLM Only
20,The mechanism controlling TRAM recruitment remains unclear but seems to be Rab11 dependent.,"p(HGNC:RAB11A) increases p(HGNC:TICAM2, loc(GO:endosome))",,,,p(HGNC:RAB11A),increases,"p(HGNC:TICAM2, loc(GO:endosome))",,,,False,False,False,False,False,0.0,LLM Only
20,The mechanism controlling TRAM recruitment remains unclear but seems to be Rab11 dependent.,"p(HGNC:RAB11A) increases p(HGNC:TICAM2, loc(GO:""phagocytic vesicle""))",,,,p(HGNC:RAB11A),increases,"p(HGNC:TICAM2, loc(GO:""phagocytic vesicle""))",,,,False,False,False,False,False,0.0,LLM Only
5,"These results seem contradictory because AKT2 phosphorylated S326, but the level of phosphorylation far exceeded the HSF1 activity induced by AKT2 (Fig. 1A-D).",,"a(TEXT:""Fig. 1A-D"") increases p(HGNC:5224 ! HSF1)",INDRA Only,,,,,"a(TEXT:""Fig. 1A-D"")",increases,p(HGNC:HSF1),False,False,False,False,False,0.0,INDRA Only
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",,p(HGNC:392 ! AKT2) increases p(FPLX:HSP90 ! HSP90),INDRA Only,,,,,p(HGNC:AKT2),increases,p(FPLX:HSP90),False,False,False,False,False,0.0,INDRA Only
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",,p(HGNC:392 ! AKT2) increases p(FPLX:HSPA ! HSPA),INDRA Only,,,,,p(HGNC:AKT2),increases,p(FPLX:HSPA),False,False,False,False,False,0.0,INDRA Only
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",,p(HGNC:391 ! AKT1) increases p(FPLX:HSP90 ! HSP90),INDRA Only,,,,,p(HGNC:AKT1),increases,p(FPLX:HSP90),False,False,False,False,False,0.0,INDRA Only
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",,p(HGNC:391 ! AKT1) increases p(FPLX:HSPA ! HSPA),INDRA Only,,,,,p(HGNC:AKT1),increases,p(FPLX:HSPA),False,False,False,False,False,0.0,INDRA Only
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",,p(HGNC:393 ! AKT3) increases p(FPLX:HSP90 ! HSP90),INDRA Only,,,,,p(HGNC:AKT3),increases,p(FPLX:HSP90),False,False,False,False,False,0.0,INDRA Only
6,"To confirm whether DNA binding of HSF1 resulted in gene transactivation, we further assessed expression of HSP70 and HSP90, well-known HSF1 target genes, in response to expression of AKT1, AKT2 or AKT3. Both HSP70 and HSP70 expression were seen to increase more in response to AKT1 than other isoforms (Fig. 2D-E).",,p(HGNC:393 ! AKT3) increases p(FPLX:HSPA ! HSPA),INDRA Only,,,,,p(HGNC:AKT3),increases,p(FPLX:HSPA),False,False,False,False,False,0.0,INDRA Only
13,"Interestingly, previous experiments demonstrated that TNF activated NF-kappaB and JNK signaling with different dynamics (Iqbal and Zaidi,)",,p(HGNC:11892 ! TNF) increases p(FPLX:NFkappaB ! NFkappaB),INDRA Only,,,,,p(HGNC:TNF),increases,p(FPLX:NFkappaB),False,False,False,False,False,0.0,INDRA Only
13,"Interestingly, previous experiments demonstrated that TNF activated NF-kappaB and JNK signaling with different dynamics (Iqbal and Zaidi,)",,p(HGNC:11892 ! TNF) increases p(FPLX:JNK ! JNK),INDRA Only,,,,,p(HGNC:TNF),increases,p(FPLX:JNK),False,False,False,False,False,0.0,INDRA Only
15,ASK1 can phosphorylate JNK and the physical interaction between A20 and ASK1 has been demonstrated.,,"p(HGNC:6857 ! MAP3K5) directlyIncreases p(FPLX:JNK ! JNK, pmod(go:0006468 ! ""protein phosphorylation""))",INDRA Only,,,,,p(HGNC:MAP3K5),directlyIncreases,"p(FPLX:JNK, pmod(go:0006468 ! ""protein phosphorylation""))",False,False,False,False,False,0.0,INDRA Only
15,A20 suppresses apoptotic JNK signaling in a TNF-dependent and independent manner via induction of ASK1 degradation.,,p(FPLX:JNK ! JNK) increases p(HGNC:11892 ! TNF),INDRA Only,,,,,p(FPLX:JNK),increases,p(HGNC:TNF),False,False,False,False,False,0.0,INDRA Only
19,We found that SLAMF1 controls trafficking of the Toll receptor-associated molecule (TRAM) from the endocytic recycling compartment (ERC) to Escherichia coli phagosomes.,,"p(HGNC:20568 ! TRAM1) partOf complex(p(HGNC:10903 ! SLAMF1), p(HGNC:20568 ! TRAM1))",INDRA Only,,,,,p(HGNC:TRAM1),partOf,"complex(p(HGNC:SLAMF1), p(HGNC:TRAM1))",False,False,False,False,False,0.0,INDRA Only
